You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Johnson and Johnson
McKesson
Baxter
Boehringer Ingelheim

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Kowa Company, Ltd. v. Orient Pharma Co., Ltd. (S.D.N.Y. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Kowa Company, Ltd. v. Orient Pharma Co., Ltd. (S.D.N.Y. 2014)

Docket   Start Trial Date Filed 2014-04-17
Court District Court, S.D. New York Date Terminated
Cause 35:271 Patent Infringement Assigned To Paul Austin Crotty
Jury Demand None Referred To
Parties KOWA COMPANY, LTD.; KOWA PHARMACEUTICALS AMERICA, INC.; NISSAN CHEMICAL INDUSTRIES, LTD.; ORIENT PHARMA CO., LTD.
Patents 6,465,477
Attorneys Adam Phillip Samansky; Andre K. Cizmarik; Andy Yu; Anthony Joseph Viola; David Cotta; David G. Conlin; Donald Joseph Mizerk; Frank G. Smith; Jennifer Lynn Dereka; John A. Bauer; John Arthur Sholar; Joseph David Rutkowski; Katherine Emma Rohlf; Kathleen B. Carr; Natalie Christine Clayton; Peter John Cuomo; Poopak Banky; Siraj Mukund Abhyankar; Stephen Yang; Steven Gerber; Thomas Hoelder Wintner; Yi Wen Wu; Zachary Winthrop Silverman
Firms Alston & Bird LLP (GA); Alston & Bird, LLP(NYC); Alston and Bird LLP; Edwards Wildman Palmer LLP (NYC); Edwards Wildman Palmer, LLP-MA; Gonzalez Saggio & Harlan LLP; Husch Blackwell LLP (Chicago); Husch Blackwell Sanders, LLP (Chicago); Locke Lord LLP (NYC); Mintz Levin Cohn Ferris Glovsky & Popeo, P.C.(NYC); Mintz Levin Cohn Ferris Glovsky and Popeo, P.C (DC)
Link to Docket External link to docket
Small Molecule Drugs cited in Kowa Company, Ltd. v. Orient Pharma Co., Ltd.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Kowa Company, Ltd. v. Orient Pharma Co., Ltd. (S.D.N.Y. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-04-18 102 PARTIAL DISMISSAL OF CLAIMS PERTAINING TO U.S. PATENT 6,465,477 PURSUANT TO F.R.C.P. 41(A)(1)(A)(ii): IT IS…Count IV ("Infringement of [United States Patent No. 6,465,477] Under 35 U.S.C. § 271(e)(2)(A)") of Plaintiffs… 17 April 2014 1:14-cv-02759 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Harvard Business School
Moodys
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.